Medtecs International Corporation Limited

TWSE:9103.TW

6.75 (TWD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) TWD.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42011 Q42011 Q22010 Q42009 Q4
Revenue 26.10126.53824.63931.60458.85285.303237.718162.60935.82233.15535.34132.96329.59132.23530.04327.55333.39728.1925.64525.96123.00332.89400000
Cost of Revenue 24.40122.28136.43923.14146.14854.529117.475111.18730.59327.85330.06827.95225.16926.97925.71322.63127.85723.8622.10521.80418.8627.74700000
Gross Profit 1.74.257-11.88.46312.70430.774120.24351.4225.2295.3025.2735.0114.4225.2564.334.9225.544.333.544.1574.1435.14700000
Gross Profit Ratio 0.0650.16-0.4790.2680.2160.3610.5060.3160.1460.160.1490.1520.1490.1630.1440.1790.1660.1540.1380.160.180.15600000
Reseach & Development Expenses 000000000000000000000000000
General & Administrative Expenses 16.1927.11810.6067.1178.1115.5958.3934.7252.3272.5692.5862.3912.0432.4952.1642.2562.0032.2572.0932.4612.772.43300000
Selling & Marketing Expenses 3.5184.1195.9846.0257.6385.98316.9655.3511.3391.2611.6011.0821.5881.0851.5010.9491.7540.9121.1840.8861.2511.02400000
SG&A 19.7111.23716.5913.14215.88811.57825.37910.0763.6663.834.1873.4733.6313.583.6653.2053.7573.1693.2773.3474.0213.45700000
Other Expenses 000000000000000000000000000
Operating Expenses 18.8610.314.63912.76414.12411.61627.5387.5873.0913.8453.6753.7373.473.8232.7973.4633.4773.1842.483.2513.4443.58900000
Operating Income -18.487-6.503-29.187-3.882-2.60618.61894.61741.5931.5741.4611.3261.2980.8441.6230.7561.6261.6971.2470.10.9730.1761.63600000
Operating Income Ratio -0.708-0.245-1.185-0.123-0.0440.2180.3980.2560.0440.0440.0380.0390.0290.050.0250.0590.0510.0440.0040.0370.0080.0500000
Total Other Income Expenses Net 1.720.7552.858-0.4430.8210.085-2.3951.275-0.545-0.973-0.605-0.833-0.658-0.8540.055-0.876-0.383-0.8690.685-0.69-0.184-0.74800000
Income Before Tax -16.767-5.748-26.329-4.325-1.78518.70392.22242.8681.0290.4880.7210.4650.1860.7690.8110.751.3140.3780.7850.283-0.0080.88800000
Income Before Tax Ratio -0.642-0.217-1.069-0.137-0.030.2190.3880.2640.0290.0150.020.0140.0060.0240.0270.0270.0390.0130.0310.011-00.02700000
Income Tax Expense 0.0480.0210.9660.4250.210.1980.6013.9750.2490.1020.1590.1130.1460.2280.2780.2641.0980.0630.6870.0260.2090.07400000
Net Income -15.708-5.358-24.897-3.699-1.72419.06692.82138.890.7770.3850.5610.3530.3410.5420.5340.4870.2150.3150.1280.255-0.2080.82100000
Net Income Ratio -0.602-0.202-1.01-0.117-0.0290.2240.390.2390.0220.0120.0160.0110.0120.0170.0180.0180.0060.0110.0050.01-0.0090.02500000
EPS -0.029-0.01-0.046-0.007-0.0030.0350.170.0710.0010.0010.0010.0010.0010.0010.0010.00100.00100.001-0.0010.00200000
EPS Diluted -0.029-0.01-0.046-0.007-0.0030.0350.170.0710.0010.0010.0010.0010.0010.0010.0010.00100.00100.001-0.0010.00200000
EBITDA -16.343-4.417-27.431-2.35-0.68520.37595.92244.2482.7932.5342.5062.5472.1393.0522.23.0992.7963.6922.4942.8452.1473.63700000
EBITDA Ratio -0.626-0.166-1.113-0.074-0.0120.2390.4040.2720.0780.0760.0710.0770.0720.0950.0730.1120.0840.1310.0970.110.0930.11100000